| Prostate Cell News 7.25 July 15, 2016 | |
|
|
|
|
TOP STORYProstate Cancer: Unexpected Results from International Phase III Study A recently published international clinical Phase III trial of a promising drug for treating advanced prostate cancer ended with surprising results: the new therapeutic agent failed to achieve any significant improvement in the overall survival of patients compared with the established standard treatment. [Press release from Medical University of Vienna discussing online prepublication in Journal of Clinical Oncology] Press Release | Abstract |
|
|
|
PUBLICATIONS(Ranked by impact factor of the journal)LABORATORY RESEARCHScientists elucidated the functional consequence of induced epithelial plasticity on androgen receptor regulation during disease progression to identify factors important for treatment-resistant and metastatic prostate cancer. [Oncotarget] Full Article Co-Targeting HSP90 and Its Client Proteins for Treatment of Prostate Cancer Researchers found that co-treatment of prostate cancer with androgen receptor (AR) antagonist enzalutamide and HSP90 inhibitor leads to more severe cell death due to a synergistic reduction of AR protein. [Mol Cancer Ther] Abstract Scientists designed hybrid molecules containing partial chemical scaffolds of enzalutamide and suberoylanilide hydroxamic acid, with weakened intrinsic pan-histone deacetylase inhibitor activities, to target heat shock protein (HSP) 90 and androgen receptor in enzalutamide-resistant prostate cancer cells [Mol Pharmacol] Abstract | Full Article Investigators explored the biological effects of metformin on prostate cancer cells and determined molecular pathways and epigenetic regulators implicated in its mechanism of action. [Prostate] Abstract Neuronal Trans-Differentiation in Prostate Cancer Cells Investigators found that LNCaP cells, subjected to a variety of stressors induced a reproducible phenotype consistent with neuronal trans-differentiation. Cells developed long cytoplasmic processes resembling neurons. [Prostate] Abstract Anti-Cancer Effect of Lambertianic Acid by Inhibiting the AR in LNCaP Cells Researchers found that lambertianic acid exerts the anticancer effect by inhibiting AR and is a valuable therapeutic agent in prostate cancer treatment. [Int J Mol Sci] Full Article Scientists described a high-content screening platform that used invasive human prostate cancer cells cultured in 3D in standard 384-well assay plates to study the activity of potential therapeutic small molecules and antibody biologics. [J Biomol Screen] Abstract CLINICAL RESEARCHEarly Evidence of Anti-PD-1 Activity in Enzalutamide-Resistant Prostate Cancer Researchers reported unexpected antitumor activity seen in metastatic castration resistant prostate cancer patients treated with the anti-programmed cell death-1 (PD-1) antibody pembrolizumab. [Oncotarget] Full Article | Press Release |
|
|
|
REVIEWSTRPM8 Puts the Chill on Prostate Cancer The authors reviewed inventory advances in understanding of the role of transient receptor potential melastatin member 8 (TRPM8) in the installation and progression of prostate cancer. [Pharmaceuticals] Full Article Visit our reviews page to see a complete list of reviews in the prostate cell research field.
|
|
SCIENCE NEWSStatins May Be Associated with Reduced Mortality in Four Common Cancers A diagnosis of high cholesterol is associated with reduced mortality and improved survival in the four most common cancers. The 14 year study from nearly one million patients found that a high cholesterol diagnosis was associated with lower risk of death in lung, breast, prostate and bowel cancers. [Press release from the European Society of Cardiology discussing research presented at Frontiers in CardioVascular Biology, Florence] Press Release |
|
| From our sponsor: Pluripotent cell isolation for regenerative medicine. Request a free wallchart from Nature.
|
|
INDUSTRY NEWSLaborie Completes Stractegic Investment in Medi-Tate LTD. Laborie Medical Technologies (Laborie), has completed an investment in Medi-Tate Ltd. Medi-Tate has developed iTind, a minimally invasive procedure to treat the symptoms of enlarged prostate in men whose primary other treatment options would be pharmaceutical therapy or surgery. [Laborie Medical Technologies] Press Release Sun Pharma announced the roll-out of Gemcitabine InfuSMART in Europe. InfuSMART is a technology in which oncology products are developed in a Ready-To-Administer bag. [Sun Pharmaceutical Industries Ltd.] Press Release (Download)
|
|
POLICY NEWSScience’s Status Shifts in New Brexit Government Three weeks after UK voters chose to leave the European Union, the country has a new prime minister, Theresa May — and a revamped administration that is poised to change science’s place in government. [Nature News] Editorial Policy: Five Cornerstones of a Global Bioeconomy Bioscience leaders such as the European Union, Japan and the United States see expanding the bioeconomy as a means of reindustrializing and creating wealth. Emerging industrial economies such as China and India see biotechnology as a nascent field of innovation in which they can quickly compete. Brazil, South Africa and Malaysia are investing to add value to their vast biological resources. [Nature News] Editorial
|
|
EVENTSNEW Nordic Life Science Days 2016 Visit our events page to see a complete list of events in the prostate cell community.
|
|
JOB OPPORTUNITIESNEW Postdoctoral Fellow – Breast, Prostate and Pancreatic Cancer (MD Anderson Cancer Center) Research Technologist – Mammary and Prostate Stem Cell Biology (STEMCELL Technologies Inc.) Clinical Laboratory Scientist (GenomeDx) Faculty Positions – Cancer Immunology (University of New Mexico Health Science Center) Postdoctoral Position – Molecular Biology/Prostate Cancer (FIBICO) Postdoctoral Associate – Cancer Research (Sanford Burnham Prebys Medical Discovery Institute) Postdoctoral Scientist – Cancer Biology (Medical Research Council) Postdoctoral Fellow – Cancer Research (University of California – San Francisco) Postdoctoral Fellow – Signaling and Epigenetic Regulation (Medical University of South Carolina) Postdoctoral Fellow – Prostate Cancer and Metabolism (Cleveland Clinic)
Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
|
|
|
Have we missed an important article or publication in Prostate Cell News? Click here to submit! Comments or suggestions? Submit your feedback here. |
|
|
Home Prostate Cell News Volume 7.25 | Jul 15 2016

Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News


